 Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Abstract #145791
Audio (mp3) recordingChad David Morris, PhD1, Jeanette A. Waxmonsky, PhD2, and Mandy Graves, MPH2. (1) Psychiatry, University of Colorado Denver, Campus Box A011-11, 4455 East 12th Avenue, Denver, CO 80220, (2) Psychiatry, University of Colorado at Denver and Health Sciences Center, Campus Box A011-11, 4455 East 12th Avenue, Denver, CO 80220, 303 717 4469, jeanette.waxmonsky@uchsc.edu
Forty-one percent (41%) of persons in the US who reported having recent mental illnesses also smoke cigarettes (Lasser et al., 2000). Previous studies have found that although quit rates for persons with mental illnesses are less than the general populations, smoking cessation rates are still substantial (e.g., Baker et al, 2006). The University of Colorado at Denver and Health Sciences Center (UCDHSC) has been developing cessation strategies tailored to this population's unique needs. In partnership with the Colorado Department of Public Health and Environment (CDPHE), our research team has developed a practical, low burden tobacco cessation toolkit based on extensive focus groups, best practices and empirical research for persons with mental illnesses and the public health settings in which they are served. In addition we have begun a two-year randomized tobacco cessation study using the toolkit's cessation strategies. This investigation is a collaboration between the UCDHSC, CDPHE, Colorado Quitline, and Community Mental Health Centers. The statewide study is examining the effectiveness of two enhanced tobacco cessation strategies (i.e., use of the Colorado Quitline and a group counseling approach for tobacco cessation tailored to persons with mental illnesses) as compared to treatment as usual (i.e., basic assessment and referral) at four dispersed community sites. Preliminary data will be presented on comparisons of cessation rates, daily cigarette consumption, as well as biologic outcomes.
Learning Objectives:
- Briefly describe the unique physiological, psychological, and social challenges facing persons with mental illnesses who use tobacco
- Review and discuss evidence-based guidelines for tobacco cessation for persons with mental illnesses
- Describe the development and dissemination of a toolkit for this population
- Provide an overview of a randomized study of tobacco cessation strategies for this population and present preliminary data
Keywords: Tobacco, Mental Illness
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA